[1]
“DETERMINANTS OF INVESTMENT OPPORTUNITIES IN PHARMACEUTICAL COMPANIES REGISTERED ON THE IDX DURING THE COVID-19 PANDEMIC”, jit, vol. 17, no. 3, pp. 535–543, Jul. 2023, doi: 10.22216/jit.v17i3.2432.